MeSH Browser

MeSH Heading: Injection Site Reaction
Tree Number(s): C23.550.340.500; C25.100.781
Unique ID: D000075662
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000075662
Scope Note: Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA.
Entry Term(s): Infusion Site Adverse Event; Infusion Site Adverse Reaction; Infusion Site Reaction; Injection Site Adverse Event; Injection Site Event
Previous Indexing: Drug-Related Side Effects and Adverse Reactions (1969-2017)
Public MeSH Note: 2018
History Note: 2018
Date Established: 2018/01/01
Date of Entry: 2017/07/11
Revision Date: 2019/07/01

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

classification (CL)

complications (CO)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M000631052
Scope Note: Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA.
Terms: Injection Site Reaction Preferred Term
Term UI T000923306
Date05/04/2017
LexicalTag NON
ThesaurusID NLM (2018); Injection Site Adverse Event
Term UI T000923316
Date05/04/2017
LexicalTag NON
ThesaurusID NLM (2018); Injection Site Event
Term UI T000923317
Date05/04/2017
LexicalTag NON
ThesaurusID NLM (2018)

Injection Site Reaction MeSH Descriptor Data 2024